Browse By

Tag Archives: INVESTING

GW Pharmaceuticals plc and Its U.S. Subsidiary Greenwich Biosciences, Inc. Announce That EPIDIOLEX® (cannabidiol) Oral Solution Has Been Descheduled And Is No Longer A Controlled Substance

– Descheduling will enable prescribing free of the previous Schedule V requirements – CARLSBAD, Calif., April 06, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its

Curaleaf Completes Acquisition of Arrow Alternative Care

Curaleaf Achieves Vertical Integration in Connecticut with the Addition of AAC Dispensaries in Three of the Largest Metro-Areas WAKEFIELD, Mass., April 6, 2020 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, has completed its acquisition of

Cresco Labs Granted Final State Approval to Open the First Adult-use Dispensary in Downtown Chicago

Sunnyside River North will open soon for online sales CHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it received an adult-use dispensing organization license from the Illinois Department of

iAnthus Announces Default of Interest Obligations to Debenture Holders on March 31, 2020

– Forms Special Committee to Oversee Strategic Alternatives Review Process and to Investigate Alleged Related Party Transactions – Appoints Canaccord Genuity as Financial Advisor – Postpones Filing of 2019 Year End Financial Statements and Corresponding Investor Call NEW YORK and TORONTO, April 6, 2020 /PRNewswire/ – iAnthus Capital Holdings, Inc. (“iAnthus”

Planet 13 Announces Release Date of Fourth Quarter 2019 Financial Results

LAS VEGAS, April 6, 2020 /PRNewswire/ – Planet 13 Holdings Inc. (CSE: PLTH) (OTCQB: PLNHF) (“Planet 13” or the “Company“), a leading vertically-integrated Nevada cannabis company announces today that it plans to release its financial results for the fourth quarter and year ended December 31st, 2019 on April 14th, 2020 aftermarket. Planet 13 Holdings will

Emerald Health Therapeutics Releases First Harvest of Premium Cannabis from its 100%-Owned Cultivation Facility in Richmond, BC

Purpose-built facility for organic cannabis production adds to Emerald’s ability to grow and sell its own unique premium-quality cannabis products Two wholly-owned operations in full production position Emerald for financial growth and sustainability VANCOUVER, British Columbia, April 06, 2020 (GLOBE NEWSWIRE) — Emerald Health Therapeutics,